{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:12:14Z","timestamp":1790946734220,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011748","name":"Phospholipid Research Center","doi-asserted-by":"publisher","award":["GDR-098\/2-1"],"award-info":[{"award-number":["GDR-098\/2-1"]}],"id":[{"id":"10.13039\/501100011748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003852","name":"Campania Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omtn.2026.102851","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:24:39Z","timestamp":1769819079000},"page":"102851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccination"],"prefix":"10.1016","volume":"37","author":[{"given":"Arianna","family":"De Chiara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Nele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Angelillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Campani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Campanile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guendalina","family":"Froechlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annagiulia","family":"Scognamiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Pellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clizia","family":"Chinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Eugster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Corbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1210-1269","authenticated-orcid":false,"given":"Giuseppe","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102851_bib1","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 \u2014 Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102851_bib2","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102851_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.102851_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2026.102851_bib5","article-title":"Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach","volume":"7","author":"Goyal","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.omtn.2026.102851_bib6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41419-022-05075-2","article-title":"RNA-based therapeutics: an overview and prospectus","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2026.102851_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2015.12.032","article-title":"Materials for non-viral intracellular delivery of messenger RNA therapeutics","volume":"240","author":"Kauffman","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102851_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2026.102851_bib9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.xphs.2020.12.006","article-title":"Addressing the Cold Reality of mRNA Vaccine Stability","volume":"110","author":"Crommelin","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.omtn.2026.102851_bib10","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.ymthe.2022.02.001","article-title":"Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine","volume":"30","author":"Muramatsu","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102851_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejpb.2023.11.007","article-title":"Evaluation of the effects of storage conditions on spray-dried siRNA-LNPs before and after subsequent drying","volume":"193","author":"Zimmermann","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.omtn.2026.102851_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2022.09.021","article-title":"Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery","volume":"351","author":"Zimmermann","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102851_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.omtm.2022.03.009","article-title":"A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery","volume":"25","author":"Gerhardt","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.102851_bib14","series-title":"Liposomes in Drug Delivery","first-page":"303","article-title":"Liposomes as DNA, mRNA and oligonucleotide delivery vectors","author":"Nele","year":"2024"},{"key":"10.1016\/j.omtn.2026.102851_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115291","article-title":"Lipid nanoparticles for RNA delivery: Self-assembling vs driven-assembling strategies","volume":"208","author":"Nele","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2026.102851_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.onano.2017.12.001","article-title":"Lipid-based core-shell nanoparticles: Evolution and potentialities in drug delivery","volume":"3","author":"Campani","year":"2018","journal-title":"OpenNano"},{"key":"10.1016\/j.omtn.2026.102851_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/admi.202000819","article-title":"Biodegradable Inorganic Nanostructured Biomaterials for Drug Delivery","volume":"7","author":"Cai","year":"2020","journal-title":"Adv. Mater. Interfaces"},{"key":"10.1016\/j.omtn.2026.102851_bib18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijpharm.2010.10.046","article-title":"Self-assembly nanoparticles for the delivery of bisphosphonates into tumors","volume":"403","author":"Salzano","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2026.102851_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biotechadv.2011.06.018","article-title":"New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study","volume":"30","author":"Marra","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.omtn.2026.102851_bib20","doi-asserted-by":"crossref","first-page":"10446","DOI":"10.18632\/oncotarget.2182","article-title":"Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid","volume":"5","author":"Porru","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtn.2026.102851_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119693","article-title":"Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA","volume":"588","author":"Campani","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtn.2026.102851_bib22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s42003-022-03639-8","article-title":"Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth","volume":"5","author":"Delle Donne","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omtn.2026.102851_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/09687860600790537","article-title":"Immunostimulation of dendritic cells by cationic liposomes","volume":"23","author":"Vangasseri","year":"2006","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.omtn.2026.102851_bib24","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.molimm.2007.04.009","article-title":"Mechanism of adjuvant activity of cationic liposome: Phosphorylation of a MAP kinase, ERK and induction of chemokines","volume":"44","author":"Yan","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omtn.2026.102851_bib25","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1021\/acs.molpharmaceut.7b01085","article-title":"Structural Characterization of Self-Assembling Hybrid Nanoparticles for Bisphosphonate Delivery in Tumors","volume":"15","author":"Ristori","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtn.2026.102851_bib26","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1002\/ejic.201500573","article-title":"Monitoring the Hemolytic Effect of Mesoporous Silica Nanoparticles after Human Blood Protein Corona Formation","volume":"2015","author":"Martinez","year":"2015","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.omtn.2026.102851_bib27","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102851_bib28","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","article-title":"The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy","volume":"31","author":"Francia","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2026.102851_bib29","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1039\/c3tb21526a","article-title":"Nanoparticle\u2013protein corona complexes govern the biological fates and functions of nanoparticles","volume":"2","author":"Gunawan","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.omtn.2026.102851_bib30","first-page":"387","article-title":"Reference values for serum proteins of common laboratory rodent strains","volume":"48","author":"Zaias","year":"2009","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.omtn.2026.102851_bib31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1258\/acb.2011.011111","article-title":"Apolipoproteins: metabolic role and clinical biochemistry applications","volume":"48","author":"Dominiczak","year":"2011","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.omtn.2026.102851_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90348-7","article-title":"Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2","volume":"11","author":"Passariello","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.102851_bib33","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/s41467-023-37795-0","article-title":"Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice","volume":"14","author":"Prompetchara","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102851_bib34","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1021\/acs.nanolett.4c06643","article-title":"A Post-Encapsulation Method for the Preparation of mRNA-LNPs via the Nucleic Acid-Bridged Fusion of mRNA-Free LNPs","volume":"25","author":"Tanaka","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.omtn.2026.102851_bib35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2144\/000112593","article-title":"Long-Term Storage of DNA-Free RNA for use in Vaccine Studies","volume":"43","author":"Jones","year":"2007","journal-title":"Biotechniques"},{"key":"10.1016\/j.omtn.2026.102851_bib36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41598-022-25737-7","article-title":"Apolipoprotein C3 facilitates internalization of cationic lipid nanoparticles into bone marrow-derived mouse mast cells","volume":"13","author":"Alam","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.102851_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2023.07.058","article-title":"The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles","volume":"361","author":"Dilliard","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtn.2026.102851_bib38","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1002\/pmic.200401276","article-title":"Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: Systematic variation between sample types and calibration of mass spectrometry data","volume":"5","author":"Haab","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.omtn.2026.102851_bib39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102851_bib40","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/s41598-018-37997-3","article-title":"Revealing membrane alteration in cells overexpressing CA IX and EGFR by Surface-Enhanced Raman Scattering","volume":"9","author":"Rusciano","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.102851_bib41","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/s41598-020-61275-w","article-title":"Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis","volume":"10","author":"Sasso","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.102851_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1156714","article-title":"Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer","volume":"14","author":"D\u2019Alise","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.102851_bib43","article-title":"Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors","volume":"32","author":"Troise","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.omtn.2026.102851_bib44","doi-asserted-by":"crossref","first-page":"e2306168","DOI":"10.1002\/smll.202306168","article-title":"Protein Corona Sensor Array Nanosystem for Detection of Coronary Artery Disease","volume":"20","author":"Lee","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.omtn.2026.102851_bib45","doi-asserted-by":"crossref","first-page":"e2000948","DOI":"10.1002\/adhm.202000948","article-title":"Analysis of the Human Plasma Proteome Using Multi-Nanoparticle Protein Corona for Detection of Alzheimer\u2019s Disease","volume":"10","author":"Corbo","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.omtn.2026.102851_bib46","doi-asserted-by":"crossref","first-page":"eaaz5380","DOI":"10.1126\/scitranslmed.aaz5380","article-title":"Elastin-like recombinamers-based hydrogel modulates post-ischemic remodeling in a non-transmural myocardial infarction in sheep","volume":"13","author":"Contessotto","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.102851_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411756","article-title":"Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach","volume":"24","author":"Previtali","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:18:52Z","timestamp":1780103932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2162253126000223"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102851","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccination","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102851"}}